通过宿主细胞 DNA 甲基化和/或 HPV 基因分型对荷兰 HPV 初筛试验中低级细胞学结果为 HPV 阳性的妇女进行分流后,阴道镜检查转诊率和 CIN3 检测率。

IF 5.7 2区 医学 Q1 ONCOLOGY
International Journal of Cancer Pub Date : 2025-03-01 Epub Date: 2024-12-16 DOI:10.1002/ijc.35289
Lisanne Verhoef, Maaike C G Bleeker, Nicole Polman, Kelsi R Kroon, Renske D M Steenbergen, Renée M F Ebisch, Willem J G Melchers, Ruud L M Bekkers, Anco C Molijn, Folkert van Kemenade, Chris J L M Meijer, Daniëlle A M Heideman, Johannes Berkhof
{"title":"通过宿主细胞 DNA 甲基化和/或 HPV 基因分型对荷兰 HPV 初筛试验中低级细胞学结果为 HPV 阳性的妇女进行分流后,阴道镜检查转诊率和 CIN3 检测率。","authors":"Lisanne Verhoef, Maaike C G Bleeker, Nicole Polman, Kelsi R Kroon, Renske D M Steenbergen, Renée M F Ebisch, Willem J G Melchers, Ruud L M Bekkers, Anco C Molijn, Folkert van Kemenade, Chris J L M Meijer, Daniëlle A M Heideman, Johannes Berkhof","doi":"10.1002/ijc.35289","DOIUrl":null,"url":null,"abstract":"<p><p>High-risk HPV (hrHPV)-based screening has led to many unnecessary colposcopy referrals, mainly because of direct referral after low-grade cytology (ASC-US/LSIL). DNA methylation and genotyping tests on ASC-US/LSIL samples have the potential to significantly improve the efficiency of screening. In this study, 12 triage strategies were constructed from FAM19A4/miR124-2 or ASCL1/LHX8 methylation, HPV16/18 or HPV16/18/31/33/45 genotyping and 1-year repeat cytology. The performance was evaluated on 215 hrHPV-positive ASC-US/LSIL samples from the IMPROVE trial (NTR5078). Performance was measured by colposcopy referral rate, positive predictive value (PPV) for detecting precancer (CIN3), and negative predictive value (NPV). To evaluate efficiency, strategies were ordered by the cumulative colposcopy referral rate after 1-year cytology and compared by the marginal PPV to detect one additional CIN3 (mPPV). The most conservative strategy (referral when HPV16/18 and FAM19A4/miR124 methylation results are positive) had a direct referral rate of 5.2%, a cumulative referral rate after 1-year cytology of 54.1%, and mPPV of 19.3%. Replacing HPV16/18 by HPV16/18/31/33/45 increased the cumulative 1-year referral rate to 54.6%, and yielded an mPPV of 10.0%. Similar results were obtained for strategies with ASCL1/LHX8 methylation. Of all strategies, referral after an HPV16/18/31/33/45 positive, ASCL1/LHX8 methylation-positive, and/or 1-year cytology-positive result yielded the highest direct and cumulative 1-year colposcopy referral rates of 64.4% and 79.1%, respectively. The NPVs after 1-year cytology varied between 98.1% and 99.4%, warranting a return to routine screening. Altogether, DNA methylation-based triage strategies are recommended as they are discriminative for CIN3 and control the number of immediate colposcopy referrals.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":"1065-1073"},"PeriodicalIF":5.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.\",\"authors\":\"Lisanne Verhoef, Maaike C G Bleeker, Nicole Polman, Kelsi R Kroon, Renske D M Steenbergen, Renée M F Ebisch, Willem J G Melchers, Ruud L M Bekkers, Anco C Molijn, Folkert van Kemenade, Chris J L M Meijer, Daniëlle A M Heideman, Johannes Berkhof\",\"doi\":\"10.1002/ijc.35289\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>High-risk HPV (hrHPV)-based screening has led to many unnecessary colposcopy referrals, mainly because of direct referral after low-grade cytology (ASC-US/LSIL). DNA methylation and genotyping tests on ASC-US/LSIL samples have the potential to significantly improve the efficiency of screening. In this study, 12 triage strategies were constructed from FAM19A4/miR124-2 or ASCL1/LHX8 methylation, HPV16/18 or HPV16/18/31/33/45 genotyping and 1-year repeat cytology. The performance was evaluated on 215 hrHPV-positive ASC-US/LSIL samples from the IMPROVE trial (NTR5078). Performance was measured by colposcopy referral rate, positive predictive value (PPV) for detecting precancer (CIN3), and negative predictive value (NPV). To evaluate efficiency, strategies were ordered by the cumulative colposcopy referral rate after 1-year cytology and compared by the marginal PPV to detect one additional CIN3 (mPPV). The most conservative strategy (referral when HPV16/18 and FAM19A4/miR124 methylation results are positive) had a direct referral rate of 5.2%, a cumulative referral rate after 1-year cytology of 54.1%, and mPPV of 19.3%. Replacing HPV16/18 by HPV16/18/31/33/45 increased the cumulative 1-year referral rate to 54.6%, and yielded an mPPV of 10.0%. Similar results were obtained for strategies with ASCL1/LHX8 methylation. Of all strategies, referral after an HPV16/18/31/33/45 positive, ASCL1/LHX8 methylation-positive, and/or 1-year cytology-positive result yielded the highest direct and cumulative 1-year colposcopy referral rates of 64.4% and 79.1%, respectively. The NPVs after 1-year cytology varied between 98.1% and 99.4%, warranting a return to routine screening. Altogether, DNA methylation-based triage strategies are recommended as they are discriminative for CIN3 and control the number of immediate colposcopy referrals.</p>\",\"PeriodicalId\":180,\"journal\":{\"name\":\"International Journal of Cancer\",\"volume\":\" \",\"pages\":\"1065-1073\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ijc.35289\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.35289","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

基于高危人乳头瘤病毒(hrHPV)的筛查导致了许多不必要的阴道镜检查转诊,主要原因是低级别细胞学检查(ASC-US/LSIL)后直接转诊。对 ASC-US/LSIL 样本进行 DNA 甲基化和基因分型检测有可能显著提高筛查效率。本研究根据 FAM19A4/miR124-2 或 ASCL1/LHX8 甲基化、HPV16/18 或 HPV16/18/31/33/45 基因分型和 1 年重复细胞学检查构建了 12 种分流策略。对来自 IMPROVE 试验(NTR5078)的 215 份 hrHPV 阳性 ASC-US/LSIL 样本进行了性能评估。评估指标包括阴道镜检查转诊率、检测癌前病变(CIN3)的阳性预测值(PPV)和阴性预测值(NPV)。为评估效率,根据 1 年细胞学检查后的累积阴道镜转诊率对策略进行排序,并根据检测出一个额外 CIN3 的边际 PPV(mPPV)进行比较。最保守的策略(HPV16/18 和 FAM19A4/miR124 甲基化结果呈阳性时转诊)的直接转诊率为 5.2%,1 年细胞学检查后的累计转诊率为 54.1%,mPPV 为 19.3%。将 HPV16/18 替换为 HPV16/18/31/33/45,1 年后的累计转诊率增至 54.6%,mPPV 为 10.0%。ASCL1/LHX8甲基化策略也得到了类似的结果。在所有策略中,HPV16/18/31/33/45 阳性、ASCL1/LHX8 甲基化阳性和/或 1 年细胞学阳性结果后转诊的直接转诊率和 1 年累计阴道镜转诊率最高,分别为 64.4% 和 79.1%。1年细胞学检查后的净现值(NPV)在98.1%和99.4%之间,因此有必要恢复常规筛查。总之,基于 DNA 甲基化的分流策略是值得推荐的,因为它对 CIN3 具有鉴别作用,并能控制立即进行阴道镜检查的转诊人数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.

High-risk HPV (hrHPV)-based screening has led to many unnecessary colposcopy referrals, mainly because of direct referral after low-grade cytology (ASC-US/LSIL). DNA methylation and genotyping tests on ASC-US/LSIL samples have the potential to significantly improve the efficiency of screening. In this study, 12 triage strategies were constructed from FAM19A4/miR124-2 or ASCL1/LHX8 methylation, HPV16/18 or HPV16/18/31/33/45 genotyping and 1-year repeat cytology. The performance was evaluated on 215 hrHPV-positive ASC-US/LSIL samples from the IMPROVE trial (NTR5078). Performance was measured by colposcopy referral rate, positive predictive value (PPV) for detecting precancer (CIN3), and negative predictive value (NPV). To evaluate efficiency, strategies were ordered by the cumulative colposcopy referral rate after 1-year cytology and compared by the marginal PPV to detect one additional CIN3 (mPPV). The most conservative strategy (referral when HPV16/18 and FAM19A4/miR124 methylation results are positive) had a direct referral rate of 5.2%, a cumulative referral rate after 1-year cytology of 54.1%, and mPPV of 19.3%. Replacing HPV16/18 by HPV16/18/31/33/45 increased the cumulative 1-year referral rate to 54.6%, and yielded an mPPV of 10.0%. Similar results were obtained for strategies with ASCL1/LHX8 methylation. Of all strategies, referral after an HPV16/18/31/33/45 positive, ASCL1/LHX8 methylation-positive, and/or 1-year cytology-positive result yielded the highest direct and cumulative 1-year colposcopy referral rates of 64.4% and 79.1%, respectively. The NPVs after 1-year cytology varied between 98.1% and 99.4%, warranting a return to routine screening. Altogether, DNA methylation-based triage strategies are recommended as they are discriminative for CIN3 and control the number of immediate colposcopy referrals.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信